Citations (85)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Amit S Kalgutkar & John R Soglia. (2005) Minimising the potential for metabolic activation in drug discovery. Expert Opinion on Drug Metabolism & Toxicology 1:1, pages 91-142.
Read now
Read now
B. Kevin Park & Neil R. Kitteringham. (1990) Drug-Protein Conjugation and its Immunological Consequences. Drug Metabolism Reviews 22:1, pages 87-144.
Read now
Read now
Patrick Colin & Eric Scherer. (1989) Simple High Performance Liquid Chromatography Determination of Captopril in Human Plasma and Cerebrospinal Fluid. Journal of Liquid Chromatography 12:4, pages 629-643.
Read now
Read now
A. F. Heald, C. E. Ita, S. M. Singhvi & B. H. Migdalof. (1985) Tissue distribution of 14C- and 35S-captopril in rats after intravenous and oral administration. Xenobiotica 15:1, pages 51-56.
Read now
Read now
Articles from other publishers (81)
Ridho Asra & Alan M Jones. (2023) Green electrosynthesis of drug metabolites. Toxicology Research 12:2, pages 150-177.
Crossref
Crossref
Amrita Salvi, Laura R. Hardy, Kimberly N. Heath, Samantha Watry, Melissa R. Pergande, Stephanie M. Cologna & Joanna E. Burdette. (2023) PAX8 modulates the tumor microenvironment of high grade serous ovarian cancer through changes in the secretome. Neoplasia 36, pages 100866.
Crossref
Crossref
Minna Khalid Danish, John P. Gleeson, David J. Brayden, Hugh J. Byrne, Jesus M. Frías & Sinéad M. Ryan. (2022) Formulation, Characterisation and Evaluation of the Antihypertensive Peptides, Isoleucine-Proline-Proline and Leucine-Lysine-Proline in Chitosan Nanoparticles Coated with Zein for Oral Drug Delivery. International Journal of Molecular Sciences 23:19, pages 11160.
Crossref
Crossref
Xinyan Dong, Jianchen Fan, Donghui Lin, Xuehui Wang, Haoyu Kuang, Lifen Gong, Chen Chen, Jie Jiang, Ningxiao Xia, Dahong He, Weida Shen, Peifang Jiang, Rong Kuang, Linghui Zeng & Yicheng Xie. (2022) Captopril alleviates epilepsy and cognitive impairment by attenuation of C3-mediated inflammation and synaptic phagocytosis. Journal of Neuroinflammation 19:1.
Crossref
Crossref
Amrita Ghosh, Aiswarya B. Pawar, Tejas Chirmade, Swaraj M. Jathar, Rahul Bhambure, Durba Sengupta, Ashok P. Giri & Mahesh J. Kulkarni. (2022) Investigation of the Captopril–Insulin Interaction by Mass Spectrometry and Computational Approaches Reveals that Captopril Induces Structural Changes in Insulin. ACS Omega 7:27, pages 23115-23126.
Crossref
Crossref
Paweł Bryniarski, Katarzyna Nazimek & Janusz Marcinkiewicz. (2022) Immunomodulatory Activity of the Most Commonly Used Antihypertensive Drugs—Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers. International Journal of Molecular Sciences 23:3, pages 1772.
Crossref
Crossref
Pablo A. Nogara, Cláudia S. Oliveira, Meire E. Pereira, Marco Bortoli, Laura Orian, Michael Aschner & João B.T. Rocha. 2022. Redox Chemistry and Biology of Thiols. Redox Chemistry and Biology of Thiols
643
677
.
Dandan Li, Linna Peng, Shishi Xing, Chunjuan He & Tianbo Jin. (2021) Genetic analysis of pharmacogenomic VIP variants in the Wa population from Yunnan Province of China. BMC Genomic Data 22:1.
Crossref
Crossref
Donald J. AbrahamDeepak K. Dalvie & Bernard Testa. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
139
.
Krishna Sriram & Paul A. Insel. (2020) Risks of ACE Inhibitor and ARB Usage in COVID‐19: Evaluating the Evidence. Clinical Pharmacology & Therapeutics 108:2, pages 236-241.
Crossref
Crossref
Jingxuan Liu, June Qin, Anna Borodovsky, Timothy Racie, Adam Castoreno, Mark Schlegel, Martin A. Maier, Tracy Zimmerman, Kevin Fitzgerald, James Butler & Akin Akinc. (2019) An investigational RNAi therapeutic targeting Factor XII (ALN-F12) for the treatment of hereditary angioedema. RNA 25:2, pages 255-263.
Crossref
Crossref
Takashi Kakimoto & Yu Onoda. 2019. Resource-Oriented Agro-sanitation Systems. Resource-Oriented Agro-sanitation Systems
79
96
.
Gilbert Moralez, Noah P. Jouett, Jun Tian, Matthew C. Zimmerman, Paul Bhella & Peter B. Raven. (2018) Effect of centrally acting angiotensin converting enzyme inhibitor on the exercise‐induced increases in muscle sympathetic nerve activity. The Journal of Physiology 596:12, pages 2315-2332.
Crossref
Crossref
R. Subramanian, X. Zhu, S. J. Kerr, J. D. Esmay, S. W. Louie, K. Z. Edson, S. Walter, M. Fitzsimmons, M. Wagner, M. Soto, R. Pham, S. F. Wilson & G. L. Skiles. (2016) Nonclinical Pharmacokinetics, Disposition, and Drug-Drug Interaction Potential of a Novel D-Amino Acid Peptide Agonist of the Calcium-Sensing Receptor AMG 416 (Etelcalcetide). Drug Metabolism and Disposition 44:8, pages 1319-1331.
Crossref
Crossref
Ting-Ting Liu, Li-Li Xiang, Jian-Ling Wang & Dong-Ying Chen. (2015) Application of capillary electrophoresis-frontal analysis for comparative evaluation of the binding interaction of captopril with human serum albumin in the absence and presence of hydrochlorothiazide. Journal of Pharmaceutical and Biomedical Analysis 115, pages 31-35.
Crossref
Crossref
Ping Chen, Murad Melhem, Jim Xiao, Mita Kuchimanchi & Juan Jose Perez Ruixo. (2015) Population pharmacokinetics analysis of AMG 416, an allosteric activator of the calcium-sensing receptor, in subjects with secondary hyperparathyroidism receiving hemodialysis. The Journal of Clinical Pharmacology 55:6, pages 620-628.
Crossref
Crossref
Pitchai Balakumar & Gowraganahalli Jagadeesh. 2015. Pathophysiology and Pharmacotherapy of Cardiovascular Disease. Pathophysiology and Pharmacotherapy of Cardiovascular Disease
751
806
.
Reto Frei, Matthew D. Wodrich, Durga Prasad Hari, Pierre-Antoine Borin, Clément Chauvier & Jérôme Waser. (2014) Fast and Highly Chemoselective Alkynylation of Thiols with Hypervalent Iodine Reagents Enabled through a Low Energy Barrier Concerted Mechanism. Journal of the American Chemical Society 136:47, pages 16563-16573.
Crossref
Crossref
Ravindra M. Kumbhare, Umesh B. Kosurkar, Pankaj K. Bagul, Abhinav Kanwal, K. Appalanaidu, Tulshiram L. Dadmal & Sanjay Kumar Banerjee. (2014) Synthesis and evaluation of novel triazoles and mannich bases functionalized 1,4-dihydropyridine as angiotensin converting enzyme (ACE) inhibitors. Bioorganic & Medicinal Chemistry 22:21, pages 5824-5830.
Crossref
Crossref
Richard E. Kast, Georg Karpel-Massler & Marc-Eric Halatsch. (2014) CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide. Oncotarget 5:18, pages 8052-8082.
Crossref
Crossref
Mesut Oktem, Pinar Ozcan, Ozlem Erdem, Cengiz Karakaya, Cahit Cenksoy, Haldun Guner, Onur Karabacak & Polat Dursun. (2014) The effect of captopril on endometriotic implants in a rat model. European Journal of Obstetrics & Gynecology and Reproductive Biology 180, pages 120-125.
Crossref
Crossref
Mingming Yu, Lilibeth Salvador, Sherwin Sy, Yufei Tang, Ravi Singh, Qi-Yin Chen, Yanxia Liu, Jiyong Hong, Hartmut Derendorf & Hendrik Luesch. (2014) Largazole Pharmacokinetics in Rats by LC-MS/MS. Marine Drugs 12:3, pages 1623-1640.
Crossref
Crossref
Tetsuya Kawabe, Kazumi Kawabe & Hreday N. Sapru. (2014) Cardiovascular effect of angiotensin-(1–12) in the caudal ventrolateral medullary depressor area of the rat. American Journal of Physiology-Heart and Circulatory Physiology 306:3, pages H438-H449.
Crossref
Crossref
Reto Frei & Jérôme Waser. (2013) A Highly Chemoselective and Practical Alkynylation of Thiols. Journal of the American Chemical Society 135:26, pages 9620-9623.
Crossref
Crossref
Hideki Arakawa, Kazumi Kawabe & Hreday N. Sapru. (2013) Angiotensin-(1-12) in the rostral ventrolateral medullary pressor area of the rat elicits sympathoexcitatory responses. Experimental Physiology 98:1, pages 94-108.
Crossref
Crossref
Vineet C. Chitravanshi, Archana Proddutur & Hreday N. Sapru. (2012) Cardiovascular actions of angiotensin‐(1–12) in the hypothalamic paraventricular nucleus of the rat are mediated via angiotensin II. Experimental Physiology 97:9, pages 1001-1017.
Crossref
Crossref
Julia Aparecida L. Souza, Miracy Muniz Albuquerque, Severino GrangeiroJrJr, Maria Fernanda Pimentel, Davi Pereira de Santana & Simone S. Simões. (2012) Quantification of captopril disulphide as a degradation product in captopril tablets using near infrared spectroscopy and chemometrics. Vibrational Spectroscopy 62, pages 35-41.
Crossref
Crossref
Angela Wolford, Thomas S. McDonald, Heather Eng, Steven Hansel, Yue Chen, Jonathan Bauman, Raman Sharma & Amit S. Kalgutkar. (2012) Immune-Mediated Agranulocytosis Caused by the Cocaine Adulterant Levamisole: A Case for Reactive Metabolite(s) Involvement. Drug Metabolism and Disposition 40:6, pages 1067-1075.
Crossref
Crossref
Antonia F. Stepan, Daniel P. Walker, Jonathan Bauman, David A. Price, Thomas A. Baillie, Amit S. Kalgutkar & Michael D. Aleo. (2011) Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States. Chemical Research in Toxicology 24:9, pages 1345-1410.
Crossref
Crossref
Amit S. Kalgutkar. 2011. Mass Spectrometry in Drug Metabolism and Disposition. Mass Spectrometry in Drug Metabolism and Disposition
43
82
.
Hideki Arakawa, Vineet C. Chitravanshi & Hreday N. Sapru. (2011) The hypothalamic arcuate nucleus: a new site of cardiovascular action of angiotensin-(1–12) and angiotensin II. American Journal of Physiology-Heart and Circulatory Physiology 300:3, pages H951-H960.
Crossref
Crossref
Vineet C. Chitravanshi & Hreday N. Sapru. (2011) Cardiovascular responses elicited by a new endogenous angiotensin in the nucleus tractus solitarius of the rat. American Journal of Physiology-Heart and Circulatory Physiology 300:1, pages H230-H240.
Crossref
Crossref
Pauliina I. Ehlers, Laura Nurmi, Anu M. Turpeinen, Riitta Korpela & Heikki Vapaatalo. (2011) Casein-derived tripeptide Ile–Pro–Pro improves angiotensin-(1–7)- and bradykinin-induced rat mesenteric artery relaxation. Life Sciences 88:5-6, pages 206-211.
Crossref
Crossref
Fabien Thaveau, Joffrey Zoll, Jamal Bouitbir, Benoît N’Guessan, Philippe Plobner, Nabil Chakfe, Jean‐Georges Kretz, Ruddy Richard, François Piquard & Bernard Geny. (2010) Effect of chronic pre‐treatment with angiotensin converting enzyme inhibition on skeletal muscle mitochondrial recovery after ischemia/reperfusion. Fundamental & Clinical Pharmacology 24:3, pages 333-340.
Crossref
Crossref
Beate Rassler. (2010) The Renin-Angiotensin System in the Development of Salt-Sensitive Hypertension in Animal Models and Humans. Pharmaceuticals 3:4, pages 940-960.
Crossref
Crossref
Karl K. Rozman, John Doull & Wayland J. HayesJr.Jr.. 2010. Hayes' Handbook of Pesticide Toxicology. Hayes' Handbook of Pesticide Toxicology
3
101
.
DAI-LIN LI, QING-CHUAN ZHENG, XUE-XUN FANG, HAI-TAO JI, JIN-GANG YANG & HONG-XING ZHANG. (2011) THEORETICAL STUDY ON POTENCY AND SELECTIVITY OF NOVEL NONPEPTIDE INHIBITORS OF MATRIX METALLOPROTEINASES MMP-2 AND MMP-9. Journal of Theoretical and Computational Chemistry 08:03, pages 491-506.
Crossref
Crossref
Makoto Takahashi, Henrianna Pang, Kiyoshi Kawabata, Nagy A. Farid & Atsushi Kurihara. (2008) Quantitative determination of clopidogrel active metabolite in human plasma by LC?MS/MS. Journal of Pharmaceutical and Biomedical Analysis 48:4, pages 1219-1224.
Crossref
Crossref
Thomas J. Bahk, Melvin D. Daniels, Juan S. Leon, Kegiang Wang & David M. Engman. (2008) Comparison of angiotensin converting enzyme inhibition and angiotensin II receptor blockade for the prevention of experimental autoimmune myocarditis. International Journal of Cardiology 125:1, pages 85-93.
Crossref
Crossref
Jack Uetrecht & William Trager. 2007. Drug Metabolism. Drug Metabolism
33
108
.
Faith E. Jacobsen, Jana A. Lewis & Seth M. Cohen. (2007) The Design of Inhibitors for Medicinally Relevant Metalloproteins. ChemMedChem 2:2, pages 152-171.
Crossref
Crossref
Muhammad T. Imtiaz, Justin H. Schripsema, Ira M. Sigar, John N. Kasimos & Kyle H. Ramsey. (2006)
Inhibition of Matrix Metalloproteinases Protects Mice from Ascending Infection and Chronic Disease Manifestations Resulting from Urogenital
Chlamydia muridarum
Infection
. Infection and Immunity 74:10, pages 5513-5521.
Crossref
Crossref
Barbara Ziegelhöffer-Mihalovicova, Nicole Arnold, Grit Marx, Andrea Tannapfel, Heinz-Gerd Zimmer & Beate Rassler. (2006) Effects of salt loading and various therapies on cardiac hypertrophy and fibrosis in young spontaneously hypertensive rats. Life Sciences 79:9, pages 838-846.
Crossref
Crossref
Jill C. M. Wait, Nimish Vaccharajani, James Mitroka, Mohammed Jemal, Sanaullah Khan, Samuel J. Bonacorsi, J. Kent Rinehart & Ramaswamy A. Iyer. (2006)
METABOLISM OF [
14
C]GEMOPATRILAT AFTER ORAL ADMINISTRATION TO RATS, DOGS, AND HUMANS
. Drug Metabolism and Disposition 34:6, pages 961-970.
Crossref
Crossref
Patrick K. K. Leong, Angela Devillez, Monica B. Sandberg, Li E. Yang, Daniel K. P. Yip, Jon B. Klein & Alicia A. McDonough. (2006) Effects of ACE inhibition on proximal tubule sodium transport. American Journal of Physiology-Renal Physiology 290:4, pages F854-F863.
Crossref
Crossref
David T. Puerta, Michael O. Griffin, Jana A. Lewis, Diego Romero-Perez, Ricardo Garcia, Francisco J. Villarreal & Seth M. Cohen. (2005) Heterocyclic zinc-binding groups for use in next-generation matrix metalloproteinase inhibitors: potency, toxicity, and reactivity. JBIC Journal of Biological Inorganic Chemistry 11:2, pages 131-138.
Crossref
Crossref
Mei-Jane Li & Shan-Yang Lin. (2005) Vibrational Spectroscopic Studies on the Disulfide Formation and Secondary Conformational Changes of Captopril–HSA Mixture after UV-B Irradiation. Photochemistry and Photobiology 81:6, pages 1404.
Crossref
Crossref
Shigeki Toyoshima, Akihiro Kanno, Tetsuya Kitayama, Koji Sekiya, Keiko Nakai, Masao Haruna, Terumasa Mino, Hiroyasu Miyazaki, Koji Yano & Keiji Yamamoto. (2005) QT PRODACT: In Vivo QT Assay in the Conscious Dog for Assessing the Potential for QT Interval Prolongation by Human Pharmaceuticals. Journal of Pharmacological Sciences 99:5, pages 459-471.
Crossref
Crossref
Jack Uetrecht. 2003. Drug Metabolizing Enzymes. Drug Metabolizing Enzymes
87
145
.
Bharti Shah, Gary Emmons, Shashank Rohatagi, Nancy E. Martin & Bradford K. Jensen. (2003) Mass Balance Study of [14C]M100240, a Dual Angiotensin-Converting Enzyme/Neutral Endopeptidase Inhibitor, in Healthy Male Subjects. American Journal of Therapeutics 10:5, pages 356-362.
Crossref
Crossref
Lisa M. Godsel, Juan S. Leon, Kegiang Wang, Jamie L. Fornek, Agostino Molteni & David M. Engman. (2003) Captopril Prevents Experimental Autoimmune Myocarditis. The Journal of Immunology 171:1, pages 346-352.
Crossref
Crossref
Pavel Majer, Paul F. Jackson, Greg Delahanty, Brian S. Grella, Yao-Sen Ko, Weixing Li, Qun Liu, Keith M. Maclin, Jana Poláková, Kathryn A Shaffer, Doris Stoermer, Dilrukshi Vitharana, Eric Yanjun Wang, Anthony Zakrzewski, Camilo Rojas, Barbara S. Slusher, Krystyna M. Wozniak, Eric Burak, Tharin Limsakun & Takashi Tsukamoto. (2003) Synthesis and Biological Evaluation of Thiol-Based Inhibitors of Glutamate Carboxypeptidase II: Discovery of an Orally Active GCP II Inhibitor. Journal of Medicinal Chemistry 46:10, pages 1989-1996.
Crossref
Crossref
Philip J. Hajduk, Suzanne B. Shuker, David G. Nettesheim, Richard Craig, David J. Augeri, David Betebenner, Daniel H. Albert, Yan Guo, Robert P. Meadows, Lianhong Xu, Michael Michaelides, Steven K. Davidsen & Stephen W. Fesik. (2002) NMR-Based Modification of Matrix Metalloproteinase Inhibitors with Improved Bioavailability. Journal of Medicinal Chemistry 45:26, pages 5628-5639.
Crossref
Crossref
C Odaka & T Mizuochi. (2000) Angiotensin-converting enzyme inhibitor captopril prevents activation-induced apoptosis by interfering with T cell activation signals. Clinical and Experimental Immunology 121:3, pages 515-522.
Crossref
Crossref
L Jia, R Pei, M Lin & X Yang. (2001) Acute and subacute toxicity and efficacy of S-nitrosylated captopril, an ACE inhibitor possessing nitric oxide activities. Food and Chemical Toxicology 39:12, pages 1135-1143.
Crossref
Crossref
Joel Menard & Arthur A. Patchett. 2001. Drug Discovery and Design. Drug Discovery and Design
13
75
.
Karl K. Rozman, John Doull & Wayland J. HayesJr.Jr.. 2001. Handbook of Pesticide Toxicology. Handbook of Pesticide Toxicology
1
93
.
Jian-Gian Qiu, Stephen Factor, Tsueng H Chang, David Knighton, Howard Nadel & Stanley M Levenson. (2000) Wound Healing: Captopril, an Angiogenesis Inhibitor, and Staphylococcus aureus Peptidoglycan. Journal of Surgical Research 92:2, pages 177-185.
Crossref
Crossref
Lee Jia, Xinping Young & Wenhu Guo. (1999) Physicochemistry, pharmacokinetics, and pharmacodynamics of S‐nitrosocaptopril crystals, a new nitric oxide donor††Abbreviations: CapNO, S‐nitrosocaptopril; Cap, Captopril; RSNOs, S‐nitrosothiols; ACE, angiotensin converting enzyme; MAP, mean arterial pressure; NO, nitric oxide.. Journal of Pharmaceutical Sciences 88:10, pages 981-986.
Crossref
Crossref
William Small, Agostino Molteni, Yoon T. Kim, Joann M. Taylor, Chung‐hsin Ts'ao & William F. Ward. (1999) Mechanism of captopril toxicity to a human mammary ductal carcinoma cell line in the presence of copper. Breast Cancer Research and Treatment 55:3, pages 223-229.
Crossref
Crossref
Lee Jia & Roland C Blantz. (1998) The effects of S-nitrosocaptopril on renal filtration and blood pressure in rats. European Journal of Pharmacology 354:1, pages 33-41.
Crossref
Crossref
M. Spotheim-Maurizot, F. Garnier, C. Kieda, R. Sabattier & M. Charlier. (1993) N-acetylcysteine and captopril protect DNA and cells against radiolysis by fast neutrons. Radiation and Environmental Biophysics 32:4, pages 337-343.
Crossref
Crossref
Haiyung Cheng & William J. Jusko. (2006) Pharmacokinetics of reversible metabolic systems. Biopharmaceutics & Drug Disposition 14:9, pages 721-766.
Crossref
Crossref
Sharif M. Mansor, Geoffrey Edwards, Phillip J. Roberts & Stephen A. Ward. (1991) The effect of malaria infection on paracetamol disposition in the rat. Biochemical Pharmacology 41:11, pages 1707-1711.
Crossref
Crossref
Sampat M. Singhvi, James E. Foley, David A. Willard & Richard A. Morrison. (1990) Disposition of Zofenopril Calcium in Healthy Subjects. Journal of Pharmaceutical Sciences 79:11, pages 970-973.
Crossref
Crossref
John H.K. Yeung. (1990) Effect of inhibition of glutathione synthesis on the immunogenicity of captopril and captoprilprotein conjugates in the mouse. Biochemical Pharmacology 40:6, pages 1235-1240.
Crossref
Crossref
A G Rumley & J R Paterson. (2016) Drug Interference in the Measurement of Serum Fructosamine. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 27:4, pages 384-385.
Crossref
Crossref
John J. RaiaJr.Jr., Joseph A. Barone, Wesley G. Byerly & Clifton R. Lacy. (2016) Angiotensin-Converting Enzyme Inhibitors: A Comparative Review. DICP 24:5, pages 506-525.
Crossref
Crossref
Gurdarshan S. Thind. (1990) Angiotensin converting enzyme inhibitors: Comparative structure, pharmacokinetics, and pharmacodynamics. Cardiovascular Drugs and Therapy 4:1, pages 199-206.
Crossref
Crossref
T. Unger, P. Gohlke & M.-G. Gruber. 1990. Pharmacology of Antihypertensive Therapeutics. Pharmacology of Antihypertensive Therapeutics
377
481
.
Stevan B. Streem & Phillip Hall. (1989) Effect of Captopril on Urinary Cystine Excretion in Homozygous Cystinuria. The Journal of Urology 142:6, pages 1522-1524.
Crossref
Crossref
G. G. Skellern. (1989) RECENT ADVANCES IN PHARMACEUTICAL CHEMISTRY—ANGIOTENSIN-CONVERTING ENZYME INHIBITORS. Journal of Clinical Pharmacy and Therapeutics 14:5, pages 341-354.
Crossref
Crossref
John H.K. Yeung & B.Kevin Park. (1989) Effect of inhibition of glutathione synthesis on the metabolism and protein conjugation of [14C]captopril in the rat. Biochemical Pharmacology 38:7, pages 1188-1192.
Crossref
Crossref
Heschi H. Rotmensch, Peter H. Vlasses & Roger K. Ferguson. (1988) Angiotensin-Converting Enzyme Inhibitors. Medical Clinics of North America 72:2, pages 399-425.
Crossref
Crossref
Karl Rozman. (2016) Disposition of Xenobiotics: Species Differences. Toxicologic Pathology 16:2, pages 123-129.
Crossref
Crossref
W. A. Creasey, R. A. Morrison, S. M. Singhvi & D. A. Willard. (1988) Pharmacokinetics of intravenous captopril in healthy men. European Journal of Clinical Pharmacology 35:4, pages 367-370.
Crossref
Crossref
M. J. Kendall. (1987) THERAPEUTIC PROGRESS?REVIEW XXIX IS THERE A ROLE FOR LOW-DOSE ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN THE TREATMENT OF MILD TO MODERATE HYPERTENSION?. Journal of Clinical Pharmacy and Therapeutics 12:6, pages 351-368.
Crossref
Crossref
Sunder M. LalHarold L. MooreKarl D. Nolph. (2020) Effects of Intraperitoneal Captopril on Peritoneal Transport in Rats. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 7:2, pages 80-85.
Crossref
Crossref
Tomiharu Ito, Yasuhiko Matsuki, Hiroyuki Kurihara & Toshio Nambara. (1987) Sensitive method for determination of captopril in biological fluids by gas chromatography?mass spectrometry. Journal of Chromatography B: Biomedical Sciences and Applications 417, pages 79-87.
Crossref
Crossref
Harold Kadin. 1987. Sulfur and Sulfur Amino Acids. Sulfur and Sulfur Amino Acids
257
264
.
Olaf H. Drummer & Bevyn Jarrott. (2006) The disposition and metabolism of captopril. Medicinal Research Reviews 6:1, pages 75-97.
Crossref
Crossref